Plasminogen activating factors from DSPA for the treatment of stroke at a dosage of 62.5 to 230 micrograms/kg

• Main Authors: SOHNGEN, WOLFGANG, SCHLEUNING, WOLF-DIETER, SOHNGEN, MARIOLA, MEDCALF, ROBERT
• Format: Patent
• Language: English
• Published: 25.06.2010
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS

Disclosed is the use of the plasminogen activating factor of Desmodus rotundus (DSPA) or a pharmaceutically acceptable salt thereof for the manufacture of an intravenously applicable medicament for the treatment of stroke wherein the dosage is from 62.5 to 230 micrograms/kg.